Projects underway (As of June, 2011)
- Business development for Shenzhen-based medical device manufacturer for a series of novel hemostatic agents (Ongoing, initiated 3Q 2008)
- Qualified sourcing of hard-to-make cytokines, antibodies and peptides for regulated drug discovery and research (Ongoing)
- Business plan development for seven Chinese start-up biotech companies (Ongoing)
- Sourcing and supervision of Chinese labs for conduct of research in animal models of infectious disease for US companies (Ongoing)
- Business development, technology transfer, and project management for a Chinese biomass conversion company (Ongoing)
- Overseas business development and new product acquisition for State-owned Chinese biotech companies (Ongoing)
- Translation of drug master files (English-Mandarin/Mandarin-
English) (As-needed basis) - GMP audits, gap analysis remediation and validation planning for Chinese facilities (As-needed basis)
- Asian business development for California-based systems integrator of mobile bioterrorism response labs (Ongoing, initiated 4Q 2010)
- Project management of Malaysian company's market entry for China, to include identification & selection of global manufacturing partner for p.pastori-expressed biopesticide, local regulatory submissions, and all aspects of commercialization. (2Q 2011)